http://www.granma.cu/ingles/cuba-i/16ener-CIM.html
Havana. January 16, 2012 Molecular Immunology Center increases exports Orfilio Peláez THE Molecular Immunology Center (CIM) had a positive year in 2011, exceeding its annual export plan and immunizing a larger number of patients suffering from advanced lung cancer with the therapeutic vaccine CIMAVAX–EGF. According to CIM directors, this institution, part of the scientific complex in West Havana, last year close to 20 countries with commercial links to CIM increased their purchases of biopharmaceutics, and the number of clinical trials abroad also grew. The institution also had excellent results in various regulatory inspections to certify good production and clinical practices, and was credited with being the best teaching unit attached to the University of Havana. Inaugurated December 5, 1994, the Molecular Immunology Center’s central objective is to develop new medicaments for the treatment of cancer and other chronic non-transferable diseases. Its results currently benefit more than 10,000 patients within the national public health system. [Non-text portions of this message have been removed]
